Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Lantik doktor asing tangani kekurangan di Sabah, Sarawak, kata MP

Ahli Parlimen Bandar Kuching Dr Kelvin Yii berkata ia langkah jangka pendek sementara kerajaan berusaha tambah baik gaji dan prospek kerjaya doktor tempatan.

Lantik doktor asing tangani kekurangan di Sabah, Sarawak, kata MP

Dato Dr Kelvin Yii, an MP from Bandar Kuching, has proposed that the government consider hiring international doctors who have been trained in Malaysia as a temporary solution to the shortage of doctors in Sabah and Sarawak. Speaking in the Dewan Rakyat, Yii cited statistics from the Medical and Health Council of Malaysia (MMA) showing that the number of doctors failing to report for placement in Sabah has risen from 2% in 2022 to 20% in 2023, projected to reach 40% by 2025 and 66% in the current month.

Yii emphasized that the Medical and Health Council of Malaysia's reports indicate a crisis, with doctor placement rates ranging from 70% to 76% in Sabah and Sarawak. Yii also pointed out that some hospitals are struggling due to a lack of personnel, such as Hospital Beluran, which has not received new doctors and now only has six, and Hospital Kudat, which only has four out of the 17 doctors assigned.

Yii compared this to Hospital Serdang in Selangor, which reportedly takes on 150 new doctors on the same day. Yii also mentioned that the actual scale of the problem may not be reflected in the official figures, as doctors who refuse placement may not be recorded as having taken up a position.

Written by urgent.news from Free Malaysia Today's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at freemalaysiatoday.com →

More in Health & Medicine

Fidson selected as regional sublicensee to expand access to influenza treatment and strengthen pandemic preparedness

Fidson joins manufacturers across Brazil, China, India, Indonesia, Malaysia, Uganda, Ukraine and Vietnam under sublicence agreements to develop and manufacture generic versions of Roche’s baloxavir…

  • Fidson Healthcare Plc selected as sublicensee for baloxavir marboxil production.
  • Medicines Patent Pool (MPP) partners with Roche for voluntary licensing.
  • Fidson CEO Biola Adebayo highlights commitment to African healthcare.

More from Monday 5 October →